Product Overview
Blocking/Immunizing peptide for anti-RIG1/RARRES3 (aa 119 to 134) antibody
Target
RIG1 / RARRES3 (aa 119 to 134)
Tag/Conjugate
Unconjugated
Application Notes
For in vitro research use only. Not intended for any diagnostic or therapeutic purpose. Not for human or animal consumption.
Format
Lyophilized powder
Storage
Shipped at ambient temperature, store at -20°C.
Antigen Description
Retinoids exert biologic effects such as potent growth inhibitory and cell differentiation activities and are used in the treatment of hyperproliferative dermatological diseases. These effects are mediated by specific nuclear receptor proteins that are members of the steroid and thyroid hormone receptor superfamily of transcriptional regulators. RARRES1, RARRES2, and RARRES3 are genes whose expression is upregulated by the synthetic retinoid tazarotene. RARRES3 is thought act as a tumor suppressor or growth regulator. [provided by RefSeq, Jul 2008]
Function
hydrolase activity; phospholipase A2 activity;
Synonyms
RARRES3; retinoic acid receptor responder (tazarotene induced) 3; retinoic acid receptor responder protein 3; HRASLS4; TIG3; RAR-responsive protein TIG3; retinoic acid-inducible gene 1; retinoid-inducible gene 1 protein; tazarotene-induced gene 3 protein; RIG1; PLA1/2-3; MGC8906;
Citations
Publication ()
Have you cited CDBP2534 in a publication?
Let us know and earn a reward for your research.